Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients. (Q51371247)
Jump to navigation
Jump to search
scientific article published on 2 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients. |
scientific article published on 2 July 2011 |
Statements
1 reference
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients. (English)
1 reference
1 reference
Yoshiharu Horie
1 reference
Shigeto Kanada
1 reference
Akiko Sarashina
1 reference
Atsushi Taniguchi
1 reference
Naoyuki Hayashi
1 reference
Eva U Graefe-Mody
1 reference
Hans-Juergen Woerle
1 reference
Klaus A Dugi
1 reference
2 July 2011
1 reference
1 reference
33
1 reference
973-989
1 reference
7
1 reference
Identifiers
1 reference